I don't dispute that - what I am saying is that the trial reported today did something quite different - they scanned every month, and commented that that was likely the reason for the good results in the "as-needed" group. So this particular trial does not directly support every-other-month treatment for Lucentis.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.